PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 11340516

[Comparative study between different conjunctival tissue adhesives].

J J Gómez González·M E Mulet Homs·J L Alió y Sanz·M M Mahiques Bujanda·Y Molina Alfonso·J M Martín Martínez
View original source ↗Export metadata ↓

Abstract

PURPOSE: To evaluate efficacy and clinical and histopathological tolerance of a new acrylic tissue adhesive (ADAL-2) compared to sutures (Vicryl) and other available tissue adhesives (Tisuacryl) for their use in conjunctival surgery. METHODS: This was an experimental study performed in New Zealand albino rabbits with conjunctival dissection and closure by ADAL-2. Groups treated with Vicryl and Tisuacryl were compared regarding efficacy, clinical, and histological tolerance at 7, 28 and 42 days. RESULTS: Efficacy was similar in the three methods of conjunctival repositioning evaluated. Tolerance to ADAL-2 was similar to that of Vicryl suture and tolerance to ADAL-2 was superior to that to Tisuacryl. Histopathological results with ADAL-2 and Tisuacryl are similar. CONCLUSIONS: ADAL-2 tissue adhesive is an efficient and very well tolerated alternative for conjunctival closure in ophthalmic surgery.

Explore related subjects

AcrylatesAnimalsAntibiotic ProphylaxisConjunctivaConjunctivitisDrug Evaluation, PreclinicalForeign-Body ReactionGranulomaMaterials TestingPolyglactin 910Postoperative ComplicationsRabbitsSuturesTissue AdhesivesTreatment OutcomeComparative StudyEnglish AbstractJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J J Gómez González, M E Mulet Homs, J L Alió y Sanz, M M Mahiques Bujanda, Y Molina Alfonso, J M Martín Martínez. 2001. [Comparative study between different conjunctival tissue adhesives].. https://pubmed.ncbi.nlm.nih.gov/11340516/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2003

pH effect of coagulation bath on the characteristics of poly(acrylic acid)-grafted and poly(4-vinylpyridine)-grafted poly(vinylidene fluoride) microfiltration membranes.

The poly(acrylic acid)-graft-poly(vinylidene fluoride) (PAAc-g-PVDF) and poly(4-vinylpyridine)-graft-poly(vinylidene fluoride) (P4VP-g-PVDF) copolymers were obtained by thermally induced molecular graft copolymerization of acrylic acid (AAc) and 4-vinylpyridine (4VP), respectively, with the ozone-pretreated poly(vinylidene fluoride) (PVDF) in N-methyl-2-pyrrolidone (NMP) solution. Microfiltration (MF) membranes were prepared from the respective copolymers by phase inversion in aqueous media. The effects of pH of the coagulation bath on the physicochemical and morphological characteristics of the membranes were investigated. The surface compositions of the membranes were determined by X-ray photoelectron spectroscopy (XPS). The surface graft concentration of the AAc polymer for the PAAc-g-PVDF MF membrane increased with decreasing pH value of the coagulation bath. Completely opposite pH-dependent behavior was observed for the surface graft concentration of the 4VP polymer in the P4VP-g-PVDF MF membranes. A substantial increase in mean pore size was observed for the PAAc-g-PVDF MF membranes cast in basic coagulation baths of increasing pH. In the case of the P4VP-g-PVDF MF membranes, a substantial increase in mean pore size was observed for membranes cast in low pH (acidic) baths. The permeation rate of aqueous solutions through the PAAc-g-PVDF and P4VP-g-PVDF MF membranes exhibited a reversible dependence on the pH of the solution, with the membranes cast near the neutral pH exhibiting the highest sensitivity to changes in permeate pH.

Acrylates↗
PubMed2003

AT1 antagonism by eprosartan lowers heart rate variability and baroreflex gain.

INTRODUCTION: Blockade of the renin-angiotensin system (RAS) by ACE inhibitors has been demonstrated to reduce total mortality in cardiovascular diseases. This advantage was attributed in part to changes of autonomic cardiovascular control, exemplified by an increase of heart rate variability (HRV) and baroreflex gain (BRG). We sought to assess the effects of the angiotensin type 1 (AT1) receptor blocker eprosartan on HRV and BRG. MATERIALS AND METHODS: In a double-blind randomized cross-over design 25 young males took eprosartan (600 mg/day) and placebo each for a period of 7 days with a wash-out period of at least 4 weeks in between. At the end of the intake phases simultaneous recordings of arterial blood pressure (AP; Finapres) and electrocardiogram (ECG) were taken. Power spectra of HRV and arterial blood pressure variability (APV) were calculated by fast Fourier transform (FFT) and served to calculate BRG. Ang-II levels were measured by radioimmunoassay. RESULTS: Eprosartan tended to lower mean AP, it slightly increased heart rate (HR) (p<0.05), and markedly increased circulating Ang-II levels (p<0.01). Eprosartan diminished the total power of HRV (p<0.05) and the BRG (p<0.01). The low/high frequency (LF/HF) ratio of HRV and the APV were not altered. CONCLUSIONS: AT1 antagonism by eprosartan lowers heart rate variability and baroreflex gain. We speculate that these findings are due to the marked increase in circulating angiotensin II (Ang II). Further studies are needed to clarify whether angiotensin type 1 (AT1) blockers with potential actions inside the blood-brain barrier (BBB) may have different effects on HRV and BRG.

Acrylates↗
PubMed2003

Synthesis of both enantiomers of a P-chirogenic 1,2-bisphospholanoethane ligand via convergent routes and application to rhodium-catalyzed asymmetric hydrogenation of CI-1008 (pregabalin).

Both enantiomers of a P-chirogenic 1,2-bisphospholanoethane ligand are synthesized via two convergent methods. The first method relies on the chiral alkylation of 1-((-)-menthoxy)phospholaneborane using a s-BuLi/(-)-sparteine derived chiral base. Only one enantiomer of the catalyst could be synthesized via this method because only one antipode of sparteine is available in nature. The second route relies on the combination of methylphosphine borane and a chiral 1,4-diol. Either enantiomer of the ligand can be synthesized via the second route from the appropriate enantiomer of the 1,4-diol. Asymmetric hydrogenation using catalyst precursor 36 on acetamidoacrylic acid derivatives provided modest to good enantioselectivity (77-95% ee) under low H(2) pressure (30 psi). Asymmetric hydrogenation of CI-1008 (pregabalin) precursors, 39 and 40, provided good enantioselectivities (92%) at high catalyst loading (1 mol %) and low pressure (30 psi). Enantiomeric excesses dropped sharply with catalyst loading at this pressure. Increasing the pressure of H(2) caused a significant increase in enantiomeric excess for low catalyst loading reactions. Several studies were undertaken to further investigate the enantioselectivity dependence on both pressure and catalyst loading.

Acrylates↗